Middleton-based Bone Care International Inc., a drug-maker that has seen its sales soar in the past two years, agreed to be bought by Genzyme Corp. for about $719 million in cash, the companies announced Wednesday. Bone Care was founded in 1987 as a division of Lunar Corp., which grew out of bone research at the University of Wisconsin-Madison and was later bought by GE Medical Imaging.
Office of Strategic Communication